Breakthrough Therapy for Stubborn Vascular Blockages Unveiled at Medical Event
Breakthrough Therapy for Stubborn Vascular Blockages Unveiled at Medical Event
Breakthrough Therapy for Stubborn Vascular Blockages Unveiled at Medical Event
A new approach to treating stubborn vascular blockages in peripheral arterial occlusive disease (PAOD) will be presented by Dr. Jawed Arjumand. The innovative therapy aims to improve outcomes for patients suffering from restricted blood flow. The announcement comes as part of a wider event showcasing advances in vascular medicine.
The gathering will also feature free health checks, including blood pressure, blood sugar tests, and vascular screenings for attendees. Dr. Arjumand, Chief of the Clinic for Angiology and Interventional Vascular Medicine, will lead discussions on the novel treatment. His method focuses on removing persistent deposits that narrow arteries, a common issue in PAOD caused by atherosclerosis.
Alongside him, Dr. Thilo Traska, Chief of General, Visceral, and Vascular Surgery, and Dr. Cornel Haupt, Chief of Radiology and Neuroradiology, will highlight interdisciplinary approaches. Their talks will cover both surgical and non-surgical techniques for treating arterial narrowing and emergencies, particularly in the carotid artery.
Attendees will have the chance to tour the catheter laboratory and a modern hybrid operating room. These visits will demonstrate the latest technologies used in diagnosing and treating vascular diseases. Free raffles for vascular checks—assessing the carotid artery and blood flow in limbs—will also be available during the event.
Blood pressure and blood sugar measurements will be offered on-site, providing participants with immediate health insights. The specialists aim to raise awareness of PAOD, a condition where reduced arterial blood flow often leads to severe complications if untreated. The event combines expert presentations with practical health assessments to highlight progress in vascular care. Participants will leave with a clearer understanding of PAOD and the latest treatment options. Free screenings and lab tours further emphasise the clinic's commitment to patient education and advanced medical solutions.
MannKind's inhalable insulin Afrezza eyes paediatric approval by 2026
A game-changing inhalable insulin could soon reach children with diabetes. Can MannKind's bold moves finally turn the tide for Afrezza?
Neocor secures $3.8M to revolutionize heart valve production by 2027
From Soviet-era labs to cutting-edge implants: Neocor's breakthrough could make life-saving heart valves accessible to millions. But first, they must win over surgeons—and regulators.
Breakthrough Therapy for Stubborn Vascular Blockages Unveiled at Medical Event
A revolutionary approach to clearing stubborn arterial deposits could transform PAOD care. Free screenings and lab tours bring cutting-edge vascular medicine to the public.
Russian schoolchildren's chronic illnesses triple by graduation, study reveals
From first grade to graduation, their health declines sharply. Experts warn of a crisis in vision, digestion, and mental well-being among young learners.